Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Review: Relationship of type 2 diabetes to human brain pathology.

Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):347-362. doi: 10.1111/nan.12476. Epub 2018 Mar 4. Review.

2.

Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.

Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, López OL, Klunk W, Hyman BT, Gómez-Isla T.

Brain. 2013 Aug;136(Pt 8):2510-26. doi: 10.1093/brain/awt171. Epub 2013 Jul 3.

3.

Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.

Ramos-Rodriguez JJ, Jimenez-Palomares M, Murillo-Carretero MI, Infante-Garcia C, Berrocoso E, Hernandez-Pacho F, Lechuga-Sancho AM, Cozar-Castellano I, Garcia-Alloza M.

Psychoneuroendocrinology. 2015 Dec;62:69-79. doi: 10.1016/j.psyneuen.2015.07.606. Epub 2015 Jul 26.

PMID:
26254770
4.

The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.

Bharadwaj P, Wijesekara N, Liyanapathirana M, Newsholme P, Ittner L, Fraser P, Verdile G.

J Alzheimers Dis. 2017;59(2):421-432. doi: 10.3233/JAD-161192. Review.

PMID:
28269785
5.
6.

Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.

Zhao Z, Ho L, Wang J, Qin W, Festa ED, Mobbs C, Hof P, Rocher A, Masur S, Haroutunian V, Pasinetti GM.

FASEB J. 2005 Dec;19(14):2081-2. Epub 2005 Sep 26.

PMID:
16186174
7.

Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.

Holler CJ, Davis PR, Beckett TL, Platt TL, Webb RL, Head E, Murphy MP.

J Alzheimers Dis. 2014;42(4):1221-7. doi: 10.3233/JAD-132450.

8.

Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.

Thal DR, Fändrich M.

Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2. No abstract available.

PMID:
25600324
9.

Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.

Infante-Garcia C, Ramos-Rodriguez JJ, Galindo-Gonzalez L, Garcia-Alloza M.

Psychoneuroendocrinology. 2016 Mar;65:15-25. doi: 10.1016/j.psyneuen.2015.12.001. Epub 2015 Dec 3.

PMID:
26708068
10.

Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.

Fawver JN, Ghiwot Y, Koola C, Carrera W, Rodriguez-Rivera J, Hernandez C, Dineley KT, Kong Y, Li J, Jhamandas J, Perry G, Murray IV.

Curr Alzheimer Res. 2014;11(10):928-40.

PMID:
25387341
11.

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, Lee VM.

Am J Pathol. 2010 Oct;177(4):1977-88. doi: 10.2353/ajpath.2010.100346. Epub 2010 Aug 27.

13.

Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.

Chai YL, Chong JR, Weng J, Howlett D, Halsey A, Lee JH, Attems J, Aarsland D, Francis PT, Chen CP, Lai MKP.

Brain Pathol. 2019 Jan;29(1):63-74. doi: 10.1111/bpa.12631. Epub 2018 Oct 17.

PMID:
30051532
14.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

15.

Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Candeias E, Duarte AI, Sebastião I, Fernandes MA, Plácido AI, Carvalho C, Correia S, Santos RX, Seiça R, Santos MS, Oliveira CR, Moreira PI.

Mol Neurobiol. 2017 Oct;54(8):6471-6489. doi: 10.1007/s12035-016-0155-1. Epub 2016 Oct 11.

PMID:
27730513
16.

Early Alzheimer-type lesions in cognitively normal subjects.

Tsartsalis S, Xekardaki A, Hof PR, Kövari E, Bouras C.

Neurobiol Aging. 2018 Feb;62:34-44. doi: 10.1016/j.neurobiolaging.2017.10.002. Epub 2017 Oct 13.

17.

Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.

Moreno-Gonzalez I, Edwards Iii G, Salvadores N, Shahnawaz M, Diaz-Espinoza R, Soto C.

Mol Psychiatry. 2017 Sep;22(9):1327-1334. doi: 10.1038/mp.2016.230. Epub 2017 Jan 3.

18.

The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Kövari E, Herrmann FR, Hof PR, Bouras C.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):498-509. doi: 10.1111/nan.12003.

19.

Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.

Edler MK, Sherwood CC, Meindl RS, Hopkins WD, Ely JJ, Erwin JM, Mufson EJ, Hof PR, Raghanti MA.

Neurobiol Aging. 2017 Nov;59:107-120. doi: 10.1016/j.neurobiolaging.2017.07.006. Epub 2017 Aug 1.

20.

A critical analysis of the 'amyloid cascade hypothesis'.

Armstrong RA.

Folia Neuropathol. 2014;52(3):211-25. Review.

Supplemental Content

Support Center